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Background:  It has been reported that high on-treatment platelet reactivity (HPR) is associated with the increasing risk of adverse cardiac events 
including revascularization. However, the relationship between HPR and plaque progression of coronary artery stenosis is unclear.
Methods:  Elective stent implantation and follow-up (mean interval, 9 months) coronary angiography were performed in 114 patients (89 men; 
mean age, 65 years) with acute coronary syndromes (ACS) taking 100 mg/day of aspirin and a thienopyridine (200 mg/day of ticlopidine for at least 
7 days or or a 300-mg loading dose of clopidogrel followed by 75 mg/day for at least 1 day). The subjects were divided into 2 groups according to 
post-treatment platelet reactivity before stenting as measured by the response to adenosine diphosphate using screen filtration pressure method: 
the fourth quartile was defined as HPR (n=28) and the remainder as low platelet reactivity (LPR) (n=86). Rapid progression was defined as ≥10% 
lumen diameter reduction of a preexisting stenosis ≥50%, ≥30% diameter reduction of a stenosis <50%, development of a new stenosis ≥30% in a 
previously normal segment, or progression of any stenosis to total occlusion.
Results:  All patients were free from thrombotic events after stent implantation. Although the level of high sensitivity C-reactive protein (hsCRP) 
before stenting was higher in patients with HPR than in those with LPR (8.4 vs 4.1mg/l, p<0.01), there were no significant differences in other 
patient characteristics between 2 groups. The rate of complex lesion of culprit artery was higher in patients with HPR than those with LPR (75 vs 
53%, p=0.04). Rapid progression of non-culprit lesions was more frequently found in patients with HPR than those with LPR (43 vs 15%, p<0.01). 
Multivariate analysis showed that hsCRP>2.0mg/l (odds ratio (OR) 24.26, p<0.01) and HPR (OR 5.98, p<0.01) were independent predictors of rapid 
progression of non-culprit lesions.
Conclusion: As well as hsCRP, HPR is associated with rapid angiographic progression of non-culprit coronary lesions in patients with ACS. 
Augmented inflammatory and platelet activity may demonstrate an accelerated situation of atherothrombosis.
